Innate or adaptive immunity? The example of natural killer cells

Science

Volumn 331, Issue 6013, 2011, Pages 44-49

  Vivier, Eric ^a,b,c,d   Raulet, David H ^e   Moretta, Alessandro ^f   Caligiuri, Michael A ^g   Zitvogel, Laurence ^b   Lanier, Lewis L ^h   Yokoyama, Wayne M ⁱ   Ugolini, Sophie ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF GENOA   (Italy)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOLOGY; IMMUNE RESPONSE; IMMUNITY; INHIBITOR;

ADAPTIVE IMMUNITY; CANCER CHEMOTHERAPY; HUMAN; INNATE IMMUNITY; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR IMMUNITY; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE; VIRUS DISEASES;

EID: 78650970845     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1198687     Document Type: Review

References (79)

1. R. B. Herberman, M. E. Nunn, D. H. Lavrin, Int. J. Cancer 16, 216 (1975).
2. R. Kiessling, E. Klein, H. Wigzell, Eur. J. Immunol. 5, 112 (1975).
3. C. Eidenschenk et al., Am. J. Hum. Genet. 78, 721 (2006).
4. S. H. Lee, T. Miyagi, C. A. Biron, Trends Immunol. 28, 252 (2007).
5. M. J. Smyth, Y. Hayakawa, K. Takeda, H. Yagita, Nat. Rev. Cancer 2, 850 (2002).
6. A. Fischer, Immunity 27, 835 (2007).
7. C. A. Jansen et al., Dev. Comp. Immunol. 34, 759 (2010).
8. A. Moffett-King, Nat. Rev. Immunol. 2, 656 (2002).
9. T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, E. Vivier, Blood 106, 2252 (2005).
10. A. Moretta et al., Trends Immunol. 26, 668 (2005).
11. A. Martín-Fontecha et al., Nat. Immunol. 5, 1260 (2004).
12. S. H. Robbins et al., PLoS Pathog. 3, e123 (2007).
13. P. Krebs et al., Blood 113, 6593 (2009).
14. D. M. Andrews et al., J. Exp. Med. 207, 1333 (2010).
15. M. Lucas, W. Schachterle, K. Oberle, P. Aichele, A. Diefenbach, Immunity 26, 503 (2007).
16. E. Mortier et al., Immunity 31, 811 (2009).
17. S. Guia et al., Blood 111, 5008 (2008).
18. J. Chaix et al., J. Immunol. 181, 1627 (2008).
19. E. Vivier, J. A. Nunès, F. Vély, Science 306, 1517 (2004).
20. Y. T. Bryceson, M. E. March, H. G. Ljunggren, E. O. Long, Immunol. Rev. 214, 73 (2006).
21. M. A. Caligiuri, Blood 112, 461 (2008).
22. T. Hughes et al., Immunity 32, 803 (2010).
23. H. Arase, E. S. Mocarski, A. E. Campbell, A. B. Hill, L. L. Lanier, Science 296, 1323 (2002).
24. H. R. Smith et al., Proc. Natl. Acad. Sci. U.S.A. 99, 8826 (2002).
25. O. Mandelboim et al., Nature 409, 1055 (2001).
26. A. Moretta et al., Annu. Rev. Immunol. 19, 197 (2001).
27. T. Walzer et al., Proc. Natl. Acad. Sci. U.S.A. 104, 3384 (2007).
28. E. Vivier, H. Spits, T. Cupedo, Nat. Rev. Immunol. 9, 229 (2009).
29. H. Veiga-Fernandes, D. Kioussis, M. Coles, J. Exp. Med. 207, 269 (2010).
30. S. Chiesa et al., Blood 107, 2364 (2006).
31. C. Bottino, R. Castriconi, L. Moretta, A. Moretta, Trends Immunol. 26, 221 (2005).
32. D. H. Raulet, N. Guerra, Nat. Rev. Immunol. 9, 568 (2009).
33. C. S. Brandt et al., J. Exp. Med. 206, 1495 (2009).
34. K. Kärre, H. G. Ljunggren, G. Piontek, R. Kiessling, Nature 319, 675 (1986).
35. F. M. Karlhofer, R. K. Ribaudo, W. M. Yokoyama, Nature 358, 66 (1992).
36. A. Moretta et al., Annu. Rev. Immunol. 14, 619 (1996).
37. N. C. Fernandez et al., Blood 105, 4416 (2005).
38. S. Kim et al., Nature 436, 709 (2005).
39. L. L. Lanier, Annu. Rev. Immunol. 23, 225 (2005).
40. A. Moretta et al., J. Exp. Med. 182, 875 (1995).
41. C. A. Stewart et al., Proc. Natl. Acad. Sci. U.S.A. 102, 13224 (2005).
42. P. Parham, Nat. Rev. Immunol. 5, 201 (2005).
43. N. Anfossi et al., Immunity 25, 331 (2006).
44. N.-S. Liao, M. Bix, M. Zijlstra, R. Jaenisch, D. Raulet, Science 253, 199 (1991).
45. P. Höglund et al., Eur. J. Immunol. 28, 370 (1998).
46. J. Zimmer et al., J. Exp. Med. 187, 117 (1998).
47. S. Cooley et al., Blood 110, 578 (2007).
48. D. H. Raulet, R. E. Vance, Nat. Rev. Immunol. 6, 520 (2006).
49. P. Höglund, P. Brodin, Nat. Rev. Immunol. 10, 724 (2010).
50. S. K. Tripathy et al., J. Exp. Med. 205, 1829 (2008).
51. J. C. Sun, L. L. Lanier, J. Exp. Med. 205, 1819 (2008).
52. C. Fauriat, M. A. Ivarsson, H. G. Ljunggren, K. J. Malmberg, J. Michaëlsson, Blood 115, 1166 (2010).
53. P. Brodin, K. Kärre, P. Höglund, Trends Immunol. 30, 143 (2009).
54. N. T. Joncker, N. C. Fernandez, E. Treiner, E. Vivier, D. H. Raulet, J. Immunol. 182, 4572 (2009).
55. N. T. Joncker, N. Shifrin, F. Delebecque, D. H. Raulet, J. Exp. Med. 207, 2065 (2010).
56. J. M. Elliott, J. A. Wahle, W. M. Yokoyama, J. Exp. Med. 207, 2073 (2010).
57. M. T. Orr, W. J. Murphy, L. L. Lanier, Nat. Immunol. 11, 321 (2010).
58. M. Terme, E. Ullrich, N. F. Delahaye, N. Chaput, L. Zitvogel, Nat. Immunol. 9, 486 (2008).
59. N. Guerra et al., Immunity 28, 571 (2008).
60. A. Iguchi-Manaka et al., J. Exp. Med. 205, 2959 (2008).
61. M. Elboim et al., J. Immunol. 184, 5637 (2010).
62. K. Imai, S. Matsuyama, S. Miyake, K. Suga, K. Nakachi, Lancet 356, 1795 (2000).
63. L. Ruggeri et al., Science 295, 2097 (2002).
64. P. Parham, K. L. McQueen, Nat. Rev. Immunol. 3, 108 (2003).
65. H. G. Ljunggren, K. J. Malmberg, Nat. Rev. Immunol. 7, 329 (2007).
66. D. Pende et al., Blood 113, 3119 (2009).
67. F. Romagné et al., Blood 114, 2667 (2009).
68. J. S. Miller et al., Blood 105, 3051 (2005).
69. S. I. Khakoo, M. Carrington, Immunol. Rev. 214, 186 (2006).
70. J. Kurtz, Trends Immunol. 26, 186 (2005).
71. A. M. Jamieson, P. Isnard, J. R. Dorfman, M. C. Coles, D. H. Raulet, J. Immunol. 172, 864 (2004).
72. J. G. O'Leary, M. Goodarzi, D. L. Drayton, U. H. von Andrian, Nat. Immunol. 7, 507 (2006).
73. S. Paust et al., Nat. Immunol. 11, 1127 (2010).
74. A. O. Dokun et al., Nat. Immunol. 2, 951 (2001).
75. J. C. Sun, J. N. Beilke, L. L. Lanier, Nature 457, 557 (2009).
76. M. A. Cooper et al., Proc. Natl. Acad. Sci. U.S.A. 106, 1915 (2009).
77. H. Wang et al., Proc. Natl. Acad. Sci. U.S.A. 104, 13744 (2007).
78. V. Kumar, M. E. McNerney, Nat. Rev. Immunol. 5, 363 (2005).
79. The authors apologize for not having been able to quote all relevant papers due to space limitations and thank C. Beziers-Lafosse (CIML) for excellent graphic assistance as well as members of their laboratories for help and discussions. E.V. and S.U. are supported by grants from the Agence Nationale de la Recherche (ANR), Ligue Nationale Contre le Cancer (Equipe Labellisée "La Ligue"), Fondation Del Duca, and institutional grants from INSERM, CNRS, and Université de la Méditerranée to the CIML. E.V. is a scholar from the Institut Universitaire de France and is a cofounder and shareholder of Innate-Pharma. D.H.R. is supported by NIH grants AI035021, AI039642, and CA093678 and is a scientific board member and shareholder of Innate-Pharma. A.M. is supported by grants awarded by Associazione Italiana per la Ricerca sul Cancro (AIRC), Ministero dell'Istruzione, dell'Università e della Ricerca, and a Special Project from the AIRC and is a cofounder and shareholder of Innate-Pharma. M.A.C. is supported by U.S. National Cancer Institute grants CA16058, CA95426, and CA68458. L.Z. is supported by Institut National du Cancer, ANR, Ligue Nationale Contre le Cancer (Equipe Labellisée "La Ligue"), and INFLARE EU grants. L.L.L. is an American Cancer Society professor and is supported by NIH grants AI068129, CA095137, and AI066897 and is a consultant for Novo Nordisk and SBI Biotech Co., Ltd. W.M.Y. is supported by the Howard Hughes Medical Institute and NIH grants AI33903, AI34385, AI51345, and AI5716.